Elanco Animal Health insider Lawrence Erik Kurzius purchased 10,000 shares Friday at $21.30 each for $213,000; ELAN traded as high as $22.67 intraday (up roughly 6.4% at the session high) though the stock was about 1.7% lower on Wednesday, and Kurzius had a prior purchase last year totaling roughly $211,000 at $10.55 per share. Separately, SAIC EVP/CFO Prabu Natarajan bought 2,000 shares at $100.49 each for $200,976, after a prior purchase last year totaling about $219,098 at $109.55, with SAIC up about 2.4% on Wednesday. These disclosed insider buys are notable to investors as potential signals of management conviction, albeit isolated transactions.
Elanco Animal Health reported an insider purchase by Lawrence Erik Kurzius of 10,000 shares at $21.30 each on Friday, a $213,000 outlay; ELAN hit an intraday high of $22.67 (about +6.4% at the session high) even as the stock was roughly 1.7% lower on Wednesday, and Kurzius previously bought approximately $211,000 of shares at $10.55 last year. Separately, SAIC EVP/CFO Prabu Natarajan purchased 2,000 shares at $100.49 for $200,976 and had a prior purchase last year totaling roughly $219,098 at $109.55; SAIC traded up about 2.4% on Wednesday. The data signals classify these events under Insider Transactions and Management & Governance with a mildly positive tone (overall sentiment score 0.25; ELAN 0.4; SAIC 0.3) and a low market impact score (0.25), indicating these are constructive but limited information. The transactions indicate management conviction but are isolated in size and timing, so the immediate implication is a potential but not definitive bullish signal that requires confirmation through follow‑on insider activity or sustained price appreciation given the intraday volatility observed for ELAN.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
